These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33 related articles for article (PubMed ID: 33684684)
1. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways. Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750 [TBL] [Abstract][Full Text] [Related]
3. Search for new biologically active compounds: Mitrović M; Djukić MB; Vukić M; Nikolić I; Radovanović MD; Luković J; Filipović IP; Matić S; Marković T; Klisurić OR; Popović S; Matović ZD; Ristić MS Dalton Trans; 2024 Jun; 53(22):9330-9349. PubMed ID: 38747564 [TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy. Sheng X; Wang MM; Zhang GD; Su Y; Fang HB; Yu ZH; Su Z Bioorg Chem; 2024 Jun; 147():107325. PubMed ID: 38583247 [TBL] [Abstract][Full Text] [Related]
5. Enhancing Bioactivity of Caković A; Ćoćić D; Živanović M; Janković N; Milivojević N; Delibašić M; Kostić M; Radojević I; Grujović M; Marković KG; Klisurić OR; Vraneš M; Bogojeski J J Med Chem; 2024 Aug; 67(15):13349-13362. PubMed ID: 39058952 [TBL] [Abstract][Full Text] [Related]
6. Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexes. Cao JJ; Tan CP; Chen MH; Wu N; Yao DY; Liu XG; Ji LN; Mao ZW Chem Sci; 2017 Jan; 8(1):631-640. PubMed ID: 29780446 [TBL] [Abstract][Full Text] [Related]
7. Raieli S; Di Renzo D; Lampis S; Amadesi C; Montemurro L; Pession A; Hrelia P; Fischer M; Tonelli R Front Oncol; 2021; 11():625207. PubMed ID: 33718189 [TBL] [Abstract][Full Text] [Related]
8. Ruthenium polypyridine complexes with triphenylamine groups as antibacterial agents against Jiang L; Ma Y; Xiong Y; Tan Y; Duan X; Liao X; Wang J Front Chem; 2022; 10():1035741. PubMed ID: 36300021 [TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway. Wang J; Liu H; Wu X; Shi C; Li W; Yuan Y; Liu Y; Xing D J Biol Inorg Chem; 2022 Aug; 27(4-5):455-469. PubMed ID: 35817878 [TBL] [Abstract][Full Text] [Related]
10. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria. Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145 [TBL] [Abstract][Full Text] [Related]
11. Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment. Li X; Wang Y; Li M; Wang H; Dong X Molecules; 2021 Dec; 27(1):. PubMed ID: 35011380 [TBL] [Abstract][Full Text] [Related]
12. Mitochondria-Targeting Metallodrugs for Cancer Therapy: Perspectives from Cell Death Modes. Li HM; Wang MM; Su Y; Fang HB; Su Z ChemMedChem; 2024 Aug; 19(15):e202400120. PubMed ID: 38696276 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial targeted rhodium(III) complexes: Synthesis, characterized and antitumor mechanism investigation. Peng YB; Tao C; Tan CP; Zhao P J Inorg Biochem; 2021 May; 218():111400. PubMed ID: 33684684 [TBL] [Abstract][Full Text] [Related]
14. Mitochondria-targeted cyclometalated rhodium(III) complexes: synthesis, characterization and anticancer research. Peng YB; He W; Niu Q; Tao C; Zhong XL; Tan CP; Zhao P Dalton Trans; 2021 Jul; 50(26):9068-9075. PubMed ID: 34113944 [TBL] [Abstract][Full Text] [Related]